The efficacy of inhaled disodium cromoglycate and glucocorticoids

Clinical and Experimental Allergy, Supplement

Volumn 26, Issue 4, 1996, Pages 8-17

  Carlsen, K H ^a,c   Larsson, K ^b  

^a Voksentoppen   (Norway)

^b NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

^c Voksentoppen   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CROMOGLYCATE DISODIUM; GLUCOCORTICOID; IMMUNOGLOBULIN E; NEDOCROMIL SODIUM; PREDNISOLONE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADRENAL SUPPRESSION; ADULT; ASTHMA; CANDIDIASIS; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EXERCISE INDUCED ASTHMA; GROWTH RETARDATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SIDE EFFECT;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; ASTHMA, EXERCISE-INDUCED; CHILD; CHILD, PRESCHOOL; CROMOLYN SODIUM; GLUCOCORTICOIDS; HUMANS; INFANT; INFANT, NEWBORN; RESPIRATORY SOUNDS;

EID: 0029954724     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Carlsen KH, Ørstavik I, Halvorsen K. Viral infections of the respiratory tract in hospitalized children. A study from Oslo during a 90-month period. Acta Paediatr Scand 1983; 72:53-8.
2. Carlsen KH, Larsen S, Ørstavik I. Acute bronchiolitis in infancy. The relationship to later obstructive airways disease and characterization of infants at risk. Eur J Respir Dis 1987; 70:86-92.
3. Martinez FD, Morgan WJ, Wright AL et al. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Group Health Medical Associates. Am Rev Respir Dis 1991; 143:312-16.
4. Martinez FD, Wright AL, Taussig LM et al. Asthma and wheezing in the first six years of life. Group Health Medical Associates. N Engl J Med 1995; 332:133-8.
5. Clough JB, Hutchinson SA, Williams JD, Holgate ST. Airway response to exercise and methacholine in children with respiratory symptoms. Arch Dis Child 1991; 66:579-83.
6. Salmon B, Wilson NM, Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child 1990; 65:401-3.
7. Lødrup Carlsen KC, Nikander K, Carlsen KH. How much nebulised budesonide reaches infants and toddlers? Arch Dis Child 1992; 67:1077-9.
8. Henry RL, Hiller EJ, Milner AD at al. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child 1984; 59:54-7.
9. Geller-Bernstein C, Levin S. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children. Respiration 1982; 43:294-8.
10. Bertelsen A, Andersen JB, Busch P et al. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. Allergy 1986; 41:266-70.
11. Furfaro S, Spier S, Drblik SP et al. Efficacy of cromoglycate in persistently wheezing infants. Arch Dis Child 1994; 71:331-4.
12. Maayan C, Itzhaki T, Bar-Yishay E et al. The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate. Pediatr Pulmonol 1986; 2:9-14.
13. Carlsen KH, Leegaard J, Larsen S, Ørstavik I. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis during the first two years of life. Arch Dis Child 1988; 63:1428-33.
14. Pedersen W, Prahl P. Jet-nebulised beclomethasone dipropionate in the management of bronchial asthma. Allergy 1987; 42:272-5.
15. Ilangovan P, Pedersen S, Godfrey S et al. Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension. Arch Dis Child 1993; 68:356-9.
16. Van Bever HP, Schuddinck L, Wojciechowski M, Stevens WJ. Aerosolized budesonide in asthmatic infants: a double blind study. Pediatr Pulmonol 1990; 9:177-80.
17. Bisgaard H, Munck SL, Nielsen JP et al. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990; 336:649-51.
18. Noble V, Ruggins NR, Everard ML, Milner AD. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child 1992; 67:285-8.
19. Connett GJ, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child 1993; 69:351-5.
20. Daugbjerg P, Brenøe E, Forchhammer H et al. A comparison between nebulized terbutaline, nebulised corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatr 1993; 82:547-51.
21. Connett G, Lenney W. Prevention of viral induced attacks using inhaled budesonide. Arch Dis Child 1993; 68:85-7.
22. Carlsen KH, Ørstavik I, Leegaard J, Høeg H. Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch Dis Child 1984; 59:310-15.
23. Stark JM, Busse WM. Respiratory virus infections and airway hyperreactivity in children. Pediatr Allergy Immunol 1991; 2:95-110.
24. McConnochie KM, Roughmann KJ. Wheezing at 8 and 13 years: changing importance of bronchiolitis and passive smoking. Pediatr Pulmonol 1989; 6:138-46.
25. Van Asperen PP, Kemp AS. The natural history of IgE sensitisation and atopic disease in early childhood. Acta Paediatr Scand 1989; 78:239-45.
26. Hattevig G, Kjellman G, Björkstén B. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol 1993; 4:182-6.
27. Bisgaard H, Pedersen S, Nikander K. Use of budesonide Turbuhaler in young children suspected of asthma. Eur Respir J 1994; 7:740-2.
28. Newth CJ, Newth CV, Turner JAP. Comparison of nebulised sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in pre-school children. A double blind study. Aust N Z J Med 1982;12:232-8.
29. Zarkovic J, Angermayr R, Covi B et al. Effectiveness and tolerance of aerosol disodium cromoglycate in children with bronchial asthma. (In German). Padiatr Padol 1991; 26:107-10.
30. Volovitz B, Amir J, Malik H et al. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 1993; 329:1703-8.
31. International Paediatric Concensus Group on Asthma. Asthma: a follow up statement from an international paediatric asthma consensus group. Arch Dis Child 1992; 67:240-8.
32. Berman BA, Fenton MM, Girsh LS et al. Cromolyn sodium in the treatment of children with severe, perennial asthma. Pediatrics 1975;55:621-629.
33. Dickson W, Cole M. Severe asthma in children - A 10-year follow-up. In: Pepys J, Edwards AM eds. The Mast Cell: Its Role in Health and Disease. London: Pitman Medical 1979; 343-52.
34. Furukawa CT, Shapiro GG, Bierman CW et al. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics 1984; 74:453-9.
35. Selcow JE, Mendelson LM, Rosen JP. Clinical benefits of cromolyn sodium aerosol (MDI) in the treatment of asthma in children. Ann Allergy 1989; 62:195-9.
36. Shapiro GG, Furukawa CT, Pierson WE et al. Double-blind evaluation of nebulised cromolyn, terbutaline, and the combination for childhood asthma. J Allergy Clin Immunol 1988; 81:449-54.
37. Morrison Smith J. A clinical trial of beclomethasone dipropionate aerosol in children and adolescents with asthma. Clin Allergy 1973; 3:249-53.
38. Thomas BC, Stanhope R, Grant DB. Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids. Acta Paediatr 1994; 83:196-9.
39. Ribeiro LB. Budesonide: safety and efficacy aspects of its long-term use in children. Pediatr Allergy Immunol 1993; 4:73-8.
40. 2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992; 146:547-54.
41. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ et al. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. Eur Respir J 1994; 7:63-8.
42. Waalkens HJ, van Essen-Zandvliet EE, Hughes MD et al. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis 1993; 148:1252-7.
43. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92:64-77.
44. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88:373-81.
45. König P, Shaffer J. The effect of drug therapy on long-term outcome in childhood asthma: do the international guidelines improve long-term outcome? Eur Respir J 1994; 7(Suppl. 18): 108s
46. Brompton Hospital/Medical Research Council Collaborative Trial. Long-term study of sodium cromoglycate in treatment of severe extrinsic or intrinsic asthma in adults. B Med J 1972; 11:383-8.
47. Eigen H, Reid JJ, Dahl R et al. Evalution of the addition cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthma. J Allergy Clin Immunol 1987; 80:612-21.
48. Petty TL, Rollins DR, Christopher K et al. Cromolyn sodium is effective in adult chronic asthmatics. Am Rev Respir Dis 1989; 139:694-701.
49. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Eng J Med 1991; 325:388-92.
50. Haahtela T, Järvinen M, Kava T et al. Effects of reducing or discontimuing budesonide in patients with mild asthma. N Engl J Med 1994; 331:700-5.
51. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148(Suppl):S1-S26.
52. Edwards AM. Sodium cromoglycate (Intal®) as an anti-inflammatory agent for the treatment of chronic asthma. Clin Exp Allergy 1994; 24:612-23.
53. Watanabe H. The effect of disodium cromoglycate against bronchial hyperresponsiveness in asthmatic children. J Asthma 1992; 29:117-20.
54. Kraemer R, Modelska K, Aebischer CC, Schoni MH. Comparison of different inhalation schedules to control childhood asthma. Agents Actions Suppl 1993; 40:211-21.
55. De Baets FM, Goeteyn M, Kerrebijn KF. The effect of two months of treatment with inhaled budesonide on bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children. Am Rev Respir Dis 1990; 142:581-6.
56. Waalkens HJ, van Essen-Zandvliet EE, Gerritsen J et al. The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Dutch CNSLD Study Group. Eur Respir J 1993; 6:652-6.
57. Hoag JE, McFadden ERJ. Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Ann Allergy 1991; 66:53-63.
58. Pepys J, Hargreave FE, Chan M, McCarthy DS. Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet 1968; ii:134-7.
59. van Essen-Zandvliet EE, Hop WC, de Jong H et al. Minor acute effect of an inhaled corticosteroid (budesonide) on bronchial hyperresponsiveness to methacholine in children with asthma. Eur Respir J 1993; 6:383-6.
60. Woolcock AJ, Jenkins CR. Clinical responses to corticosteroids. In: Kaliner MA, Barnes PJ, Persson CGA (eds). Asthma. Its Pathology and Treatment. New York: Marcel Dekker, 1991: 633-5.
61. Johansson S-Å. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis 1982;122:167-75.
62. Lee TH, Anderson SD. Heterogeneity of mechanisms in exercise-induced asthma. Thorax 1985; 40:481-7.
63. Taylor WR, Newacheck PW. Impact of childhood asthma upon health. Pediatrics 1992; 90:657-62.
64. Anderson SD. Drugs and the control of exercise-induced asthma. Eur Respir J 1993; 6:1090-2.
65. Comis A, Valletta EA, Sette L et al. Comparison of nedocromil sodium and sodium cromoglycate administered by pressurized aerosol, with and without a spacer device in exercise-induced asthma in children. Eur Respir J 1993; 6:523-6.
66. Benedictis FM, Tuteri G, Bertotto A et al. Comparison of the protective effects of cromolyn sodium and nedocromil sodium in the treatment of exercise-induced asthma in children. J Allergy Clin Immunol 1994; 94:684-8.
67. Morton AR, Ogle SL, Fitch KD. Effects of nedocromil sodium, cromolyn sodium, and a placebo in exercise-induced asthma. Ann Allergy 1992; 68:143-8.
68. Zanconato S, Baraldi E, Santuz Petal. Effect of inhaled disodium cromoglycate and albuterol on energy cost of running in asthmatic children. Pediatr Pulmonol 1990; 8:240-4.
69. Baraldi E, Santuz P, Magagnin G et al. Effect of disodium cromoglycate on ventilation and gas exchange during exercise in asthmatic children with a postexertion FEV1 fall less than 15 percent. Chest 1994; 106:1083-8.
70. Woolley M, Anderson SD, Quigley BM. Duration of protective effect of terbutaline sulphate and cromolyn sodium alone and in combination on exercise-induced asthma. Chest 1990; 97:39-45.
71. König P, Jaffe P, Godfrey S. Effect of corticosteroids on exercise-induced asthma. J Allergy Clin Immunol 1974; 54:14-19.
72. Carlsen KH, Boe J. Exercise-induced asthma in children. Eur Respir J 1993; 6:614-16.
73. Kimata H, Yoshida A, Ishioka C, Mikawa H. Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cells in vitro. Clin Exp Immunol 1991; 84:395-9.
74. Loh RKS, Jabara HH, Geha RS. Disodium cromoglycate inhibits Sμ to S deletional switch recombination and IgE synthesis in human B cells. J Exp Med 1994; 180:663-71.
75. Nüsslein HG, Weber G, Kalden JR. Synthetic glucocorticoids potentiate IgE synthesis. Allergy 1994; 49:365-70.
76. Klebl FH, Weber G, Kalden JR, Nüsslein HG. In vitro and in vivo effect of glucocorticoids on IgE and IgG subclass secretion. Clin Exp Allergy 1994; 24:1022-9.
77. Zieg G, Lack G, Harbeck RJ et al. In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol 1994; 94:222-30.
78. Mansfield LE. Disappearance of allergic reaction to cromolyn (cromoglycate) by avoidance and then reintroduction. J Asthma 1991; 28:447-50.
79. Wass U, Plaschke P, Björkander J, Belin L. Assay of specific IgE antibodies to disodium cromoglycate in serum from a patient with an immediate hypersensitivity reaction. J Allergy Clin Immunol 1988; 81:750-7.
80. Ruiz RG, Price JF. Growth and adrenal responsiveness with budesonide in young asthmatics. Respir Med 1994; 88:17-20.
81. Merkus PJ, van Essen-Zandvliet EE, Duiverman EJ et al. Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993; 91:1121-6.
82. Wolthers OD, Pedersen S. Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone diproprionate. Arch Dis Child 1993; 68:673-6.
83. Wolthers OD, Pedersen S. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics 1992; 89:839-42.
84. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995;151:1715-19.
85. Ninan TK, Reid IW, Carter PE et al. Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma. Thorax 1993; 48:599-602.
86. Nicolaizik WH, Marchait JL, Pearce MA, Warner JO. Endocrine and lung function in asthmatic children on inhaled corticosteroids. Am J Respir Crit Care Med 1994; 150:624-8.
87. Bisgaard H, Pedersen S, Damkjasr Nielsen M, Osterballe O. Adrenal function in asthmatic children treated with inhaled budesonide. Acta Paediatr Scand 1991; 80:213-17.
88. Prahl P. Adrenocortical suppression following treatment with beclomethasone and budesonide. Clin Exp Allergy 1991; 21:145-6.
89. Williams SJ. Side effects of inhaled steroids. In: Hargreave FE, Hogg JC, Malo J, Toogood JH eds. Glucocorticoids and Mechanisms of Asthma. Clinical and Experimental Aspects. Amsterdam: Excerpta Medica 1989: 68-86.
90. Priftis K, Everard ML, Milner AD. Unexpected side-effects of inhaled steroids: a case report. Eur J Pediatr 1991; 150:448-9.
91. Zwaan CM, Odink RJ, Delemarre-van de Waal HA et al. Acute adrenal insufficiency after discontinuation of inhaled corticosteroid therapy Lancet 1992; 340:1289-90.
92. Turpeinen M, Sorva R, Juntunen-Backman K. Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. J Allergy Clin Immunol 1991; 88:384-9.
93. Capewell S, Reynolds S, Shuttleworth D et al. Purpura and dermal thinning associated with high dose inhaled corticosteroids. Br Med J 1990; 300:1548-51.
94. Mak VHF, Melchor R, Spiro SG. Easy bruising as a side-effect of inhaled corticosteroids. Eur Respir J 1992; 5:1068-74.
95. Agertoft L, Pedersen S. Importance of inhalation device on the effect of budesonide. Arch Disease Child 1993; 69:130-3.
96. Shapiro GG, Sharpe M, DeRouen TA et al. Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma. J Allergy Clin Immunol 1991; 88:742-8.
97. Faurschou P, Bing J, Edman G, Engel A-M. Comparison between sodium cromoglycate MDI: metered dose inhaler and beclomethasone dipropionate MDI in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double dummy randomized, parallel-group study. Allergy 1994; 49:656-60.
98. Anderson SD, du Toit JI, Rodwell LT, Jenkins CR. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5 percent saline aerosol. Outcome before and during treatment with aerosol corticosteroids in patients with asthma. Chest 1994; 105:673-80.